News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Results> Bio-Thera Solutions (02315.HK) Swings to RMB104 million Net Profit in 1Q26
Bio-Thera Solutions (02315.HK) announced that for 1Q26, revenue prepared under the China Accounting Standards amounted to approximately RMB433 million, representing a YoY increase ...
Reset
Send
The window will close in 5 seconds
<Results> Bio-Thera Solutions (02315.HK) Swings to RMB104 million Net Profit in 1Q26
Close
Recommend
2
Positive
1
Negative
0
 
 

Bio-Thera Solutions (02315.HK)  -1.140 (-2.235%)    Short selling $1.03M; Ratio 3.369%   announced that for 1Q26, revenue prepared under the China Accounting Standards amounted to approximately RMB433 million, representing a YoY increase of 73.68%. Net profit attributable to shareholders of the listed company was approximately RMB104 million, compared with a loss of RMB13.2458 million in the same period last year. Basic EPS was RMB0.23.

Dividend History
Announce DateEventParticular
2026/03/26FinalNo Dividend
2025/08/28InterimNo Dividend
2025/03/26FinalNo Dividend
2024/08/28InterimNo Dividend

During the period, research and development investment amounted to approximately RMB118 million, up 20.17% YoY. R&D investment accounted for 27.18% of revenue, representing a YoY decrease of 12.1 ppts. (ss/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)
Auto-translated by AI
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.